%20Inline-CMYK_White%20BG.webp)
Our leadership team is comprised of individuals with diverse backgrounds and expertise, all united by a shared vision of improving global health outcomes. Together, we strive to lead by example, fostering a culture of collaboration, accountability, and transparency.
Robert Mackie, CEO and Chairman of bioLytical, leads with over 30 years of business expertise. His entrepreneurial journey includes co-founding a major mobile communications firm in Western Canada. Transitioning to real estate, he earned his license from the University of British Columbia and built a robust international portfolio in commercial real estate management and development. A dedicated philanthropist, Robert supports local charities, emphasizing sports and youth education. At bioLytical, he focuses on combating global epidemics through the innovative one-minute INSTI testing platform.
Hans Croukamp is the Chief Operating Officer of bioLytical, also serving on its board. With a career spanning over 30 years, he brings a wealth of leadership experience to the role, focusing on enhancing organizational capabilities, operations, and staff performance. Hans assumed the COO position in 2018 after previously directing operations as the Senior Operations Director, where he led various Lean initiatives to ensure product excellence and supported growth within the strict regulatory environment of medical devices. Originally from South Africa, he moved to Canada in 2001, bringing extensive experience in directing operations across multiple industries including construction, leisure, and interiors. Hans also has significant experience in manufacturing for a leading commercial refrigeration company and has managed global sales in security and signage, particularly for casinos worldwide.
Josh brings over 20 years of experience in the biotech and pharma sectors to his role at bioLytical, where he leads the science and technical team responsible for the INSTI product line's global expansion. His expertise spans research, quality management, and product development, and he has a proven track record of leading teams to commercialize products successfully. Before bioLytical, Josh held roles in pharma, biotech, and cannabis industries, where he developed strategies for product lifecycle management. He also co-founded a company specializing in cannabinoid analysis, serving as a scientific advisor. Josh holds a Ph.D. in Biology from the University of Victoria and has taught at three universities, focusing on genetics and protein chemistry.
Lawrence Wong, CPA, CGA, is bioLytical’s Chief Financial Officer, boasting over 15 years of experience across diverse industries. As a finance expert, he is known for devising and implementing solutions that enhance efficiency and align financial operations with corporate goals. Lawrence leads the strategy and direction of all financial activities at bioLytical. He joined the company in 2018, having previously held senior finance roles in the beverage alcohol sector, including a stint as Corporate Controller for a top Canadian wine agency. There, he managed accounting, finance, IT, business intelligence, and supply chain, playing a key role in strategic initiatives such as sales growth, acquisitions, debt restructuring, and financing. Lawrence is a Chartered Professional Accountant and earned his Bachelor of Business Administration from Simon Fraser University.
Brent Fleming, CPHR, serves as bioLytical’s Chief People Officer, bringing over 25 years of expertise in pioneering people and culture initiatives in fast-growing companies. With a varied career spanning automotive to gaming, Brent has developed impactful programs like Blueprint for Quality and Talent Without Fear, contributing to significant market growth. Previously, as VP of HR at a gaming firm, he crafted strategies that earned accolades in Alberta and Vancouver. At bioLytical, Brent leads innovative efforts like The Zone and plans for self-directed teams, aligning with the company’s vision and his commitment to continuous learning.
David brings over two decades of sales and marketing expertise across multiple industries to his role at bioLytical. He is pivotal in formulating the company's comprehensive commercial strategy, which encompasses sales planning, marketing, communications, and account management. David is key to commercializing the INSTI product line and manages both domestic and international sales. Prior to joining bioLytical in 2021, he spent five years in pharmaceuticals, excelling in key account management and sales, where he surpassed revenue goals and expanded market share. David holds a Bachelor of Arts from the University of Western Ontario, a Lean Six Sigma Yellow Belt, and a Certified Sales Professional designation, alongside numerous professional accolades. His career is marked by robust sales growth and the enhancement of team capabilities and professional networks.
Ana brings over 12 years of experience in quality and compliance within the pharmaceutical, biotech, and medical devices sectors to her role at bioLytical. She oversees the company's regulatory and quality processes, crucial for securing regulatory approvals, commercializing the INSTI product line, and upholding the QMS to meet MDSAP/ISO 13485 standards. Rejoining bioLytical in 2021, Ana previously excelled in research, audit, and consultancy, developing quality systems for all stages of medical device production. As a former Lead Auditor for BSI, she evaluated the compliance of medical device manufacturers. Ana holds a Ph.D. in Chemistry from the University of Miami, a Regulatory Affairs Certification, and a strong record in scholarly research, making her adept at launching innovative medical technologies.
